RAPP
Financials
- Market Capitalization 2.34 B
- Employee 84
- Founded 2022
- CEO N/A
- Website www.rapportrx.com
- Headquarter Delaware, United States
- FIGI BBG01FRNQ4P1
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1579 |  OGN Organon & Co. Common Stock | 13.77 USD | +0.07% | +0.22% | +1.62% | +89.67% | 3.62 B USD | ||
| 1716 |  MBX MBX Biosciences, Inc. - Common Stock | 63.00 USD | -5.11% | -4.88% | -2.84% | +321.69% | 3.03 B USD | ||
| 1957 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 149.97 USD | -0.24% | +7.11% | +3.79% | +103.07% | 2.16 B USD | ||
| 2022 |  GENB Generate Biomedicines, Inc. - Common Stock | 15.33 USD | -2.79% | -8.53% | +16.93% | +2.20% | 1.97 B USD |
Frequently asked questions about Rapport Therapeutics, Inc. Common Stock
What is the Rapport Therapeutics, Inc. Common Stock stock price today?
The current price of Rapport Therapeutics, Inc. Common Stock (RAPP) is 48.77. Over the past 24 hours, the stock has changed by -4.05%. Follow the RAPP chart for real-time price dynamics.
What is the stock ticker of Rapport Therapeutics, Inc. Common Stock?
Rapport Therapeutics, Inc. Common Stock trades under the ticker RAPP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rapport Therapeutics, Inc. Common Stock stock going up?
RAPP has changed by +1.27% over the last week, +16.98% over the last month, and +86.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Rapport Therapeutics, Inc. Common Stock?
Rapport Therapeutics, Inc. Common Stock currently has a market capitalization of 2.34 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Rapport Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Rapport Therapeutics, Inc. Common Stock reported earnings of -1.19 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Rapport Therapeutics, Inc. Common Stock revenue for the last quarter?
Rapport Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Rapport Therapeutics, Inc. Common Stock net income for the last quarter?
Rapport Therapeutics, Inc. Common Stock reported net income of -56.62 M for the last quarter. The previous quarter showed -19.86 M, which means net income changed by -185.11%.
How many employees does Rapport Therapeutics, Inc. Common Stock have?
As of the latest available data, Rapport Therapeutics, Inc. Common Stock has 84 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Rapport Therapeutics, Inc. Common Stock stock?
You can buy Rapport Therapeutics, Inc. Common Stock (RAPP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rapport Therapeutics, Inc. Common Stock stock?
Investing in Rapport Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RAPP chart and related analysis on metatrader.com as part of your research.